The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries

Reports of COVID-19-associated mucormycosis have been increasing in frequency since early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes and hyperglycaemia often have an inflammatory state that could be potentiated by the activation of antiviral immunity to SARS...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoenigl, Martin, Seidel, Danila, Carvalho, Agostinho, Rudramurthy, Shivaprakash M, Arastehfar, Amir, Gangneux, Jean-Pierre, Nasir, Nosheen, Bonifaz, Alexandro, Araiza, Javier, Klimko, Nikolai, Serris, Alexandra, Lagrou, Katrien, Meis, Jacques F, Cornely, Oliver A, Perfect, John R, White, P Lewis, Chakrabarti, Arunaloke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789240/
https://www.ncbi.nlm.nih.gov/pubmed/35098179
http://dx.doi.org/10.1016/S2666-5247(21)00237-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789240/
https://www.ncbi.nlm.nih.gov/pubmed/35098179
http://dx.doi.org/10.1016/S2666-5247(21)00237-8

Ejemplares similares